Moderna to secure a UK presence with $1B+ in new manufacturing and R&D facilities

As Moderna keeps up the fight against Covid-19, recently winning authorization in the US for children under the age of five, the company is also looking to make a serious investment in the UK.

According to the UK government, Moderna will be looking to establish a vaccine research center and a manufacturing site for a series of vaccines.

Moderna will establish this new mRNA Innovation and Technology Centre to develop mRNA vaccines for a wide range of respiratory diseases, including Covid-19.

For the manufacturing of the vaccines, the company will open a large-scale mRNA manufacturing center which will manufacture their Covid-19 vaccine and other vaccines for flu and RSV. Construction is expected to start as early as this year, with the first vaccines due to be produced in 2025.

While there is no confirmation on the size, cost or even the location of the new facility, and inquiries from…
Click here to view original post

Be the first to comment

Leave a Reply

Your email address will not be published.


*